Wen Zhao

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Topics

Cardiac Resynchronization Therapy

Molecular Dynamics Simulations

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Zhang-Xu He, Ge Gao, Hui Qiao, Guan-Jun Dong, Zengyangzong Dan, Ya-Lan Li, Yu-Ruo Qi, Qian Zhang, Shuo Yuan, Hong-Min Liu, Jianzeng Dong, Wen Zhao, Li-Ying Ma
Discovery of 1,2,4-Triazole-3-thione Derivatives as Potent and Selective DCN1 Inhibitors for Pathological Cardiac Fibrosis and Remodeling. Journal of medicinal chemistry (2024)
Ming-Jie Huang, Jiale Xu, Hui Qiao, Wen Zhao, Lihua Huang
Design, Synthesis, and Evaluation of the Selective and Orally Active LSD1 Inhibitor with the Potential of Treating Heart Failure. Journal of medicinal chemistry 67 (15) (2024)
Ming-Jie Huang, Jiale Xu, Hui Qiao, Wen Zhao, Lihua Huang
Design, Synthesis, and Evaluation of the Selective and Orally Active LSD1 Inhibitor with the Potential of Treating Heart Failure. Journal of medicinal chemistry (2024)
Ming-Jie Huang, Jiale Xu, Hui Qiao, Wen Zhao, Lihua Huang
Design, Synthesis, and Evaluation of the Selective and Orally Active LSD1 Inhibitor with the Potential of Treating Heart Failure. Journal of medicinal chemistry 67 (15) (2024)
Guan-Jun Dong, Jiahui Zuo, Junlin Yu, Jiale Xu, Ge Gao, Guo-Bo Li, Wen Zhao, Bin Yu
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of medicinal chemistry (2022)
Kai Tang, Le-Min Jiao, Yu-Ruo Qi, Tian-Ci Wang, Ya-Lan Li, Jia-Le Xu, Zi-Wei Wang, Bin Yu, Hong-Min Liu, Wen Zhao
Discovery of Novel Pyrazole-Based KDM5B Inhibitor TK - 129 and Its Protective Effects on Myocardial Remodeling and Fibrosis. Journal of medicinal chemistry 65 (19) (2022)
Guan-Jun Dong, Jiahui Zuo, Junlin Yu, Jiale Xu, Ge Gao, Guo-Bo Li, Wen Zhao, Bin Yu
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of medicinal chemistry 66 (1) (2022)
Guan-Jun Dong, Jiahui Zuo, Junlin Yu, Jiale Xu, Ge Gao, Guo-Bo Li, Wen Zhao, Bin Yu
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of medicinal chemistry 66 (1) (2022)
Guan-Jun Dong, Jiahui Zuo, Junlin Yu, Jiale Xu, Ge Gao, Guo-Bo Li, Wen Zhao, Bin Yu
Structure-Based Design of the Indole-Substituted Triazolopyrimidines as New EED-H3K27me3 Inhibitors for the Treatment of Lymphoma. Journal of medicinal chemistry 66 (1) (2022)
Zhang-Xu He, Qi An, Bo Wei, Wen-Juan Zhou, Bing-Fei Wei, Yun-Peng Gong, Xin Zhang, Ge Gao, Guan-Jun Dong, Jin-Ling Huo, Xin-Hui Zhang, Fei-Fei Yang, Hong-Min Liu, Li-Ying Ma, Wen Zhao
Discovery of Potent and Selective 2-(Benzylthio)pyrimidine-based DCN1-UBC12 Inhibitors for Anticardiac Fibrotic Effects. Journal of medicinal chemistry 65 (1) (2021)
Wen-Juan Zhou, Liying Ma, Lina Ding, Qian Guo, Zhangxu He, Jing Yang, Hui Qiao, Lingyu Li, Jie Yang, Shimin Yu, Lili Zhao, Shaomeng Wang, Hong-Min Liu, Zhenhe Suo, Wen Zhao
Correction to Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction. Journal of medicinal chemistry 63 (20) (2020)
Wen-Juan Zhou, Liying Ma, Lina Ding, Qian Guo, Zhangxu He, Jing Yang, Hui Qiao, Lingyu Li, Jie Yang, Shimin Yu, Lili Zhao, Shaomeng Wang, Hong-Min Liu, Zhenhe Suo, Wen Zhao
Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M Interaction. Journal of medicinal chemistry 62 (11) (2019)